Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1975-06-26
1977-06-28
Rosen, Sam
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424311, 424274, A61K 31175, A61K 3122, A61K 3140
Patent
active
040326594
ABSTRACT:
It has been found that compounds having a stereochemically unencumbered access to a nitrogen-nitrogen bond have antiviral activity in extremely low dose ranges. Hydrazine, hydrazine derivatives and related compounds have been found to be active in protecting animals against disease caused by both DNA and RNA type viruses at doses of about 250 picograms to 250 micrograms per kilograms of host body weight.
REFERENCES:
usui, Chem. Abst., vol. 70, (1969), p. 76696x.
Hegarty Charles Paul
Pietryk Helen C.
American Home Products Corporation
Rosen Sam
Weigman Joseph Martin
LandOfFree
Method of viral chemoprophylaxis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of viral chemoprophylaxis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of viral chemoprophylaxis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1522063